Free Trial

Inhibrx (INBX) SEC Filings & 10K Form

Inhibrx logo
$14.84 +0.29 (+1.99%)
(As of 10:47 AM ET)

Recent Inhibrx SEC Filings

DateFilerForm TypeView
11/14/2024
3:50 PM
Inhibrx (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
06/10/2024
4:10 PM
Inhibrx (Filer)
Form 15-12G
06/03/2024
4:55 PM
HALVORSEN OLE ANDREAS (Reporting)
Inhibrx (Issuer)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VIKING GLOBAL INVESTORS LP (Reporting)
Viking Global Opportunities GP LLC (Reporting)
Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting)
Viking Global Opportunities Parent GP LLC (Reporting)
Viking Global Opportunities Portfolio GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
4:56 PM
Inhibrx (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G/A
05/31/2024
3:30 PM
Inhibrx Biosciences, Inc. (Issuer)
Inhibrx (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
5:22 PM
Inhibrx (Issuer)
Lappe Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
5:23 PM
Inhibrx (Issuer)
MANHARD KIMBERLY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
5:23 PM
Inhibrx (Issuer)
Vuori Kristiina MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
5:21 PM
Deck Kelly (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
5:21 PM
Eckelman Brendan P. (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
5:22 PM
FORSYTH DOUGLAS (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
5:22 PM
Inhibrx (Issuer)
Kayyem Jon Faiz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
3:32 PM
Inhibrx (Filer)
Form POSASR
05/30/2024
3:33 PM
Inhibrx (Filer)
Form S-8 POS
05/30/2024
3:33 PM
Inhibrx (Filer)
Form S-8 POS
05/30/2024
3:34 PM
Inhibrx (Filer)
Form S-8 POS
05/30/2024
3:34 PM
Inhibrx (Filer)
Form S-8 POS
05/30/2024
7:39 AM
Inhibrx (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
05/28/2024
3:55 PM
Eckelman Brendan P. (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2024
5:15 PM
Eckelman Brendan P. (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
3:44 PM
Inhibrx Biosciences, Inc. (Issuer)
Inhibrx (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/22/2024
8:54 AM
Eckelman Brendan P. (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2024
8:48 PM
Inhibrx (Filer)
Form DEFA14A
05/17/2024
4:29 PM
Inhibrx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:08 PM
Inhibrx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
3:42 PM
Inhibrx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:36 PM
Deck Kelly (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
3:22 PM
Deck Kelly (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/22/2024
3:54 PM
Deck Kelly (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
2:56 PM
Deck Kelly (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/21/2024
3:36 PM
Deck Kelly (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2024
3:50 PM
Deck Kelly (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/15/2024
3:46 PM
Deck Kelly (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
3:48 PM
Eckelman Brendan P. (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:22 PM
Deck Kelly (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2024
10:34 AM
Eckelman Brendan P. (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2024
5:04 PM
Eckelman Brendan P. (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
3:20 PM
Deck Kelly (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
2:28 PM
Deck Kelly (Reporting)
Inhibrx (Subject)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
3:41 PM
Deck Kelly (Reporting)
Inhibrx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
1:58 PM
Deck Kelly (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
A conspiracy Trump won’t unseal (Ad)

New documentary reveals the lost wealth-building secret hidden deep within ancient religious texts from almost every civilization… an investment one expert says is “so perfect that only God could have created it.” Watch it now to discover how this asset that you’ve likely never considered before can produce returns so safe, secure, and endless it is nothing short of miraculous.

This is the untold, true story of God’s Investment.
03/04/2024
5:26 PM
Deck Kelly (Reporting)
Inhibrx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
4:26 PM
Inhibrx (Filer)
Form PREM14A
02/28/2024
8:10 AM
Inhibrx (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2024
8:12 AM
Inhibrx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2024
3:30 PM
Inhibrx (Filer)
Form DEFA14A
01/29/2024
4:25 PM
BlackRock Inc. (Filed by)
Inhibrx (Subject)
Form SC 13G/A
01/23/2024
4:25 PM
Inhibrx (Filer)
Form DEFA14A
01/23/2024
9:10 AM
Inhibrx (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/23/2024
5:35 AM
Inhibrx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
5:38 AM
Inhibrx (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:INBX) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners